Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

Company Overview - Jazz Pharmaceuticals is a specialty biopharmaceutical company based in Dublin, Ireland, focusing on neuroscience and oncology [11]. Investment Ratings - Jazz Pharmaceuticals holds a Zacks Rank of 3 (Hold) and has a VGM Score of A, indicating a solid position in the market [11]. - The company is considered a potential top pick for growth investors, with a Growth Style Score of B [11]. Earnings Forecast - For the current fiscal year, Jazz Pharmaceuticals is forecasted to achieve year-over-year earnings growth of 6.2% [11]. - In the last 60 days, three analysts have revised their earnings estimates upwards, with the Zacks Consensus Estimate increasing by $0.12 to $22.19 per share [12]. - The company has an average earnings surprise of 3.2%, suggesting a positive trend in earnings performance [12].